Cargando…

Omicron variant in the current SARS-CoV-2 pandemic

Detalles Bibliográficos
Autores principales:	Nasiri, Kaveh, Dimitrova, Aleksandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association for Dental Sciences of the Republic of China 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767799/ https://www.ncbi.nlm.nih.gov/pubmed/35070134 http://dx.doi.org/10.1016/j.jds.2022.01.003

Ejemplares similares

The role of povidone-iodine in managing of SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

The role of telemedicine tools in managing the new chapter of SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Managing halitosis during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

White coat hypertension during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2023)

The role of laser irradiation in dental therapy during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh
Publicado: (2022)

Managing intentional replantation of teeth during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2023)

Elimination of Enterococcus faecalis in the root canal during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Managing vertical root fracture in dentistry during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2023)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

Eliminating Candida albicans for endodontic treatment purposes during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2023)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

What Is New With Omicron Variant of SARS-CoV-2 in Children?
por: Bittmann, Stefan, et al.
Publicado: (2022)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Highly efficient respirators are needed for the Omicron variant of SARS-CoV-2
por: Mattiuzzi, C., et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variants in Bangladesh: Pandemic to endemic
por: Jubair, Mohammad, et al.
Publicado: (2023)

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab
por: Vellas, Camille, et al.
Publicado: (2022)

“Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants”
por: Vera-Lise, Ihm, et al.
Publicado: (2022)

Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients
por: Chimon, Alice, et al.
Publicado: (2022)

Two SARS-CoV-2 serology assays detect antibodies in the sera of individuals diagnosed with SARS-CoV-2 Omicron variant
por: Conklin, Justin, et al.
Publicado: (2022)

High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection
por: Zheng, Jing, et al.
Publicado: (2022)

It is not the time to relax yet: masks are still needed for the Omicron variant of SARS-CoV-2
por: Lowe, Scott, et al.
Publicado: (2022)

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
por: Ahava, Maarit J., et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
por: Vellas, Camille, et al.
Publicado: (2022)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022)

Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant
por: Migueres, Marion, et al.
Publicado: (2022)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2022)

Omicron: A SARS‐CoV‐2 variant of real concern
por: Gattinger, Pia, et al.
Publicado: (2022)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
por: Bojkova, Denisa, et al.
Publicado: (2022)

Assessment of the Analytical Sensitivity of 10 Lateral Flow Devices against the SARS-CoV-2 Omicron Variant
por: Deerain, Joshua, et al.
Publicado: (2022)

Cohorting inpatients with Omicron and Delta variants of Sars-CoV-2 does not increase rates of mixed infection
por: Davies, Jessica, et al.
Publicado: (2022)

Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea
por: Guo, Zihao, et al.
Publicado: (2022)

The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2: First-in-human evidence
por: Sang, Ling, et al.
Publicado: (2022)

Interferon-α-2b Nasal Spray for Treating SARS-CoV-2 Omicron Variant-Infected Children
por: Zhou, Jianguo, et al.
Publicado: (2023)

Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
por: Taenaka, Ryutaro, et al.
Publicado: (2022)

Comparison of the amount of SARS-CoV-2 exhaled by Delta and Omicron patients
por: Lina, Liu, et al.
Publicado: (2022)

Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern
por: Yadav, Pragya D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d0l3o88jul3fkvq2dgel586fpc